IAGG Symposium  |  Targeting Aging: The Next Big Medical Breakthrough

Jul 25

IAGG Symposium | Targeting Aging: The Next Big Medical Breakthrough View MoreBACK



As a co-host of the 2017 IAGG World Congress of Gerontology and Geriatrics, AFAR is pleased to present


Targeting Aging: The Next Big Medical Breakthrough
Tuesday July 25
8:00 a.m. - 9:30 a.m.
Moscone West conference center
San Francisco

The symposium will discuss the extent to which recent basic research has identified the major underlying processes of aging, and how recent advances in basic research are on the verge of being translated into specific human therapies that promise to delay multiple diseases and conditions of aging as a group.



Chaired by:

Steven N. Austad, PhD
AFAR Scientific Director and Distinguished Professor and Department Chair at the University of Alabama, Birmingham
“Overview: Current status of basic aging research”


Featuring presentations by:

Nir R. Barzilai, MD
AFAR Deputy Scientific Director, and Director of the Institute for Aging Research at Albert Einstein College of Medicine
“Targeting Aging with Metformin (TAME)”


Matt Kaeberlein, PhD
Professor, University of Washington
“Translational Geroscience: Targeting mTOR signaling to promote healthy longevity”

James L. Kirkland, MD, PhD
AFAR President Elect and Director of the Robert and Arlene Kogod Center on Aging at the Mayo Clinic
“The Path Towards Translating Senolytic Drugs into Clinical Treatments”


This symposium is part of the Biological Sciences Program of the IAGG World Congress.
For the complete schedule, click here.

For further discussion, join AFAR from 12 - 3 p.m. on July 25 for a luncheon symposium on biotechnology and longevity
featuring leaders from Unity Biotech and AFAR experts. For ticket information, click here.